Delivery Order 11316021D1003WHO-11316021F0009WHO
- Not listed
- This is a federal contract award to Minuteclinic, L.L.C., a subsidiary of CVS Health Corporation, for the provision of COVID-19 testing services. The $1,938,595.00 delivery order contract was awarded by the Executive Office of the President's White House Office, a civilian agency, on March 19, 2021. The contract is for time and materials pricing and has a completion date of September 19, 2021. The award is part of a broader $20 million Indefinite Delivery Contract between Minuteclinic and the...
- This is a $209,835,907.00 definitive, fixed price incentive contract awarded to Minuteclinic, L.L.C., a subsidiary of CVS Health Corporation, by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. The contract, titled "Increase Community Access to Testing (ICATT)", is for the provision of COVID-19 testing services nationwide, leveraging Minuteclinic's network of retail health clinics. This award builds upon previous COVID-19...
- Minuteclinic, L.L.C. was awarded a $71.5 million definitive contract by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Administration to support COVID-19 self-swab and point-of-care testing as part of a public-private partnership. Performance will take place in Woonsocket, Rhode Island through September 2021. As the prime contractor and a subsidiary of CVS Health Corporation, Minuteclinic will deliver fixed-price incentive COVID-19 testing services to...
- This $498,152 firm-fixed price contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS) to CVS Health Clinical Trial Services LLC, a subsidiary of CVS Health Corporation. The contract is for CVS Health to provide clinical decision support to align COVID-19 testing and vaccine breakthrough monitoring, as well as identify, secure, and produce related data. This contract is not associated with...
- This is a new task order awarded to Walgreen Co. (Walgreens) under a multi-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the Department of Health and Human Services (HHS) for vaccination services. The task order, valued at $40,024.60, provides HHS with access to a variety of vaccination solutions to assist in the voluntary administration of influenza and COVID-19 vaccines to multiple populations. The contract has a period of performance through November 23, 2024 and utilizes...
- The Department of Health and Human Services, through its Office of the Assistant Secretary for Administration, awarded Walgreen Co. a $820.1 million definitive contract to support COVID-19 self-swab and point-of-care testing as part of a public-private partnership. Walgreens will leverage its network of over 9,000 locations across the United States to provide testing capabilities and services. The fixed-price incentive contract runs from April 2020 through September 2021 to address coronavirus...
- This is a Definitive Contract awarded by the Centers for Disease Control and Prevention (CDC) to Walgreens (Walgreen CO.) with a Ceiling Value of $306,212,245.35. The contract, titled "Increasing Community Access to Testing (ICATT)", is for maintaining approximately 20,000 pharmacy and community-based COVID-19 testing sites nationwide through June 2028. The contract has a 6-month base period and five 6-month option periods. This is not a set-aside requirement, and the NAICS code is...
- This federal contract award is for retail pharmacy influenza immunization services, with a ceiling value of $1,154,994.41. The contract was awarded to Walgreen Co., doing business as Walgreens, by the Department of Veterans Affairs' Veterans Integrated Service Network 19. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation. Walgreens is a major federal contractor and grant recipient, leveraging its nationwide network of...
- This is a federal contract award to Walgreen CO., doing business as Walgreens, by the Indian Health Service (IHS), a civilian agency under the Department of Health and Human Services. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price pricing type, valued at $1,065,845.69. The contract is for a 6-month option extension to provide pharmaceutical and healthcare services, including COVID-19 testing, vaccine administration, and medical supply distribution. The contract...
- This is a $20,405 firm-fixed-price purchase order awarded by the Bureau of Administration to Mckesson Medical-Surgical Inc., a subsidiary of Mckesson Corporation, to provide COVID-19 vaccines for various federal posts. The contract has an ultimate completion date of March 21, 2024. Mckesson Medical-Surgical Inc. is a major supplier of medical products and equipment to the U.S. federal government, including for COVID-19 response efforts. The company has an extensive history of providing...
- 11316021D1003WHOIndefinite Delivery Contract
- 11316021D1003WHO-11316021F0009WHODelivery Order
This federal contract award was issued by the Executive Office of the President's White House Office, a civilian agency, to Minuteclinic, L.L.C., a subsidiary of CVS Health Corporation. The $7,495,752.17 delivery order contract is for the provision of COVID-19 testing and vaccination services leveraging Minuteclinic's retail health clinic network. The contract is a time and materials agreement with no set-aside designation. This award builds upon Minuteclinic's existing work supporting the federal government's pandemic response, including over $294 million in prior COVID-19 testing services for the Executive Office of the President and the Department of Health and Human Services. The contract will fund self-swab kits, point-of-care testing, and the operation of Minuteclinic's retail clinics to expand access to testing and vaccination in the Washington, D.C. area through September 2022. Minuteclinic holds a $20 million Indefinite Delivery Contract with the White House Office to deliver rapid COVID-19 testing services in the nation's capital through September 2023.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00008 | Funding Only Action | ($114k) | 1/29/25 | |
| P00007 | Funding Only Action | ($205k) | 1/15/25 | |
| P00006 | Funding Only Action | $550.0k | 9/20/22 | |
| P00005 | Other Administrative Action | $0 | 9/15/22 | |
| P00004 | Funding Only Action | $500.0k | 9/8/22 |